Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

IMMUNOTHERAPY

Checkpoint inhibition in the bone marrow

The coupling of blood platelets bearing anti-programmed cell death protein 1 antibodies to haematopoietic stem cells enables delivery of checkpoint-blockade therapy to bone marrow to promote T-cell-mediated control of leukaemia in mice.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Re-activation of AML-targeting T cells via delivery of aPD-1 to the bone marrow of leukaemic mice by means of a platelet–HSC construct.

References

  1. Zhang, L., Gajewski, T. F. & Kline, J. Blood 114, 1545–1552 (2009).

    Article  CAS  Google Scholar 

  2. Boddu, P. et al. Leuk. Lymphoma 59, 790–802 (2018).

    Article  CAS  Google Scholar 

  3. Hu, Q. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-018-0310-2 (2018).

  4. Vidriales, M. B. et al. Ann. Hematol. 67, 217–222 (1993).

    Article  CAS  Google Scholar 

  5. Van den Hove, L. E. et al. Leuk. Res. 22, 175–184 (1998).

    Article  Google Scholar 

  6. Yang, H. et al. Leukemia 28, 1280–1288 (2014).

    Article  CAS  Google Scholar 

  7. Coles, S. J. et al. Leukemia 29, 1952–1954 (2015).

    Article  CAS  Google Scholar 

  8. Alexandrov, L. B. et al. Nature 500, 415–421 (2013).

    Article  CAS  Google Scholar 

  9. Roh, W. et al. Sci. Transl. Med. 9, eaah3560 (2017).

    Article  Google Scholar 

  10. Li, S. et al. Nat. Med. 22, 792–799 (2016).

    Article  CAS  Google Scholar 

  11. Geiger, T. L. & Rubnitz, J. E. Discov. Med. 19, 275–284 (2015).

    PubMed  PubMed Central  Google Scholar 

  12. Daver, N. et al. Leukemia 32, 1094–1105 (2018).

    Article  CAS  Google Scholar 

  13. Klinger, M., Benjamin, J., Kischel, R., Stienen, S. & Zugmaier, G. Immunol. Rev. 270, 193–208 (2016).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Martina Seiffert.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seiffert, M. Checkpoint inhibition in the bone marrow. Nat Biomed Eng 2, 793–794 (2018). https://doi.org/10.1038/s41551-018-0319-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41551-018-0319-6

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research